Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer

Conditions:   Rectal Neoplasm Malignant Carcinoma;   Chemoradiotherapy;   Neoadjuvant Therapy;   Predictive Biomarkers;   Adenocarcinoma Interventions:   Radiation: Radiation;   Drug: Capecitabine-Irinotecan Combination Sponsors:   Fudan University;   Liaoning Tumor Hospital & Institute;   Harbin Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials